Literature DB >> 8653876

Latent hypoparathyroidism in children with conotruncal cardiac defects.

B F Cuneo1, C B Langman, M N Ilbawi, V Ramakrishnan, A Cutilletta, D A Driscoll.   

Abstract

BACKGROUND: DiGeorge anomaly is characterized by hypoplasia or atresia of the thymus and parathyroid glands resulting in T cell-mediated deficiency, hypocalcemic hypoparathyroidism, and conotruncal cardiac defects. It usually is associated with deletions of chromosomal region 22q11. We hypothesized that the stimulated (secretory reserve) but not the constitutive secretion of parathyroid hormone would be reduced in normocalcemic children with conotruncal cardiac defects but no overt immune deficiency and would be related to the presence of a deletion in the DiGeorge chromosomal region of 22q11. METHODS AND
RESULTS: Blood-ionized calcium and serum-intact parathyroid hormone were measured at baseline and seven more times during hypocalcemia induced during cardiopulmonary bypass in 22 patients and 10 control subjects with an atrial septal defect. Chromosomal deletions were detected by fluorescent in situ hybridization and DNA dosage analysis. There were no differences in basal calcium and parathyroid hormone levels between patients and control subjects. All had increased parathyroid hormone in response to hypocalcemia; despite lower calcium levels, parathyroid hormone levels were lower in patients. The parathyroid hormone secretory reserve in 14 of 22 patients was reduced compared with control subjects; 4 of the 14 had deletions.
CONCLUSIONS: A significant number of children with conotruncal cardiac defects have normocalcemia and a normal constitutive level of parathyroid hormone but deficient parathyroid hormone secretory reserve; about 30% also have 22q11 deletions. Such children may be at risk for the later development of hypocalcemic hypoparathyroidism.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8653876     DOI: 10.1161/01.cir.93.9.1702

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  8 in total

Review 1.  Genetic Disorders of Parathyroid Development and Function.

Authors:  Rebecca J Gordon; Michael A Levine
Journal:  Endocrinol Metab Clin North Am       Date:  2018-10-12       Impact factor: 4.741

2.  Influence of chromosome 22q11.2 microdeletion on postoperative calcium level after cardiac-correction surgery.

Authors:  Li Shen; Haitao Gu; Dongjing Wang; Chi Yang; Zhengfeng Xu; Hua Jing; Yongzhong Jiang; Yibing Ding; Huacheng Hou; Zhijuan Ge; Shilin Chen; Xuming Mo; Long Yi
Journal:  Pediatr Cardiol       Date:  2011-06-16       Impact factor: 1.655

3.  Characteristics of 22q 11.2 deletion syndrome undiagnosed until adulthood: an example suggesting the importance of psychiatric manifestations.

Authors:  Kenta Furuya; Yosuke Sasaki; Taizo Takeuchi; Yoshihisa Urita
Journal:  BMJ Case Rep       Date:  2015-06-08

4.  Hypoparathyroidism and 22q11 deletion syndrome.

Authors:  S C Taylor; G Morris; D Wilson; S J Davies; J W Gregory
Journal:  Arch Dis Child       Date:  2003-06       Impact factor: 3.791

Review 5.  The DiGeorge anomaly.

Authors:  R Hong
Journal:  Clin Rev Allergy Immunol       Date:  2001-02       Impact factor: 10.817

6.  A patient with 22q11.2 deletion syndrome: case report.

Authors:  Sema Kabataş Eryılmaz; Firdevs Baş; Ali Satan; Feyza Darendeliler; Rüveyde Bundak; Hülya Günöz; Nurçin Saka
Journal:  J Clin Res Pediatr Endocrinol       Date:  2009-02-06

7.  Endocrine and Growth Disorders in Taiwanese Children With 22q11.2 Deletion Syndrome.

Authors:  Han-Yi Lin; Wen-Yu Tsai; Yi-Ching Tung; Shih-Yao Liu; Ni-Chung Lee; Yin-Hsiu Chien; Wuh-Liang Hwu; Cheng-Ting Lee
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-31       Impact factor: 5.555

8.  Case fatality rate and associated factors in patients with 22q11 microdeletion syndrome: a retrospective cohort study.

Authors:  Gabriela M Repetto; M Luisa Guzmán; Iris Delgado; Hugo Loyola; Mirta Palomares; Guillermo Lay-Son; Cecilia Vial; Felipe Benavides; Karena Espinoza; Patricia Alvarez
Journal:  BMJ Open       Date:  2014-11-06       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.